Kazuho Kojima

Kazuho Kojima

Auto-generated profile, based on publicly available information

Kazuho Kojima

Department of Neurology, Chiba Rosai Hospital, Japan (A.H., K. Kurumada, K. Kojima)

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2018 in Journal of Neurology, Neurosurgery & Psychiatry
Verified
Journal Article
Open access
PDF file
KWKeisuke Watanabe
Keisuke Watanabe
SHShigeki Hirano
Shigeki Hirano
KKKazuho Kojima
Kazuho Kojima
KNKengo Nagashima
Kengo Nagashima
HMHiroki Mukai
Hiroki Mukai
SMSonoko Misawa
Sonoko Misawa
Objective To assess the cerebral blood flow (CBF) in patients with diabetic neuropathic pain, and its changes after duloxetine therapy. Methods Using iodine-123-N-isopropyl-p-iodoamphetamine single-photon emission computed tomography (IMP-SPECT), we performed a cross-sectional study of 44 patients with diabetes, and compared CBF in those with (n = 24) and without neuropathic pain (n = 20). In patients with neuropathic pain, we also longitudinally assessed changes in CBF 3 months after treatment with duloxetine. Results IMP-SPECT with voxel-based analyses showed a significant increase in cerebral blood flow in the right anterior cingulate cortex and a decrease in the left ventral striatum in patients with neuropathic pain, compared with those without pain. After duloxetine treatment, volume of interest analyses revealed a decrease in cerebral blood flow in the anterior cingulate cortex in patients with significant pain relief but not in non-responders. Furthermore, voxel-based whole brain correlation analyses demonstrated that greater baseline CBF in the anterior cingulate cortex was associated with better pain relief on the numerical rating scale. Conclusions Our results suggest that the development of neuropathic pain is associated with increased activity in the anterior cingulate cortex, and greater baseline activation of this region may predict treatment responsiveness to pharmacological intervention. Trial registration number UMIN000017130;Results.

1 January 2016 in Internal Medicine
Verified
Journal Article
Open access
YAYuya Aotsuka
Yuya Aotsuka
AUAkiyuki Uzawa
Akiyuki Uzawa
KNKazutaka Nishimura
Kazutaka Nishimura
KKKazuho Kojima
Kazuho Kojima
MYMika Yamaguchi
Mika Yamaguchi
SKSatoshi Kuwabara
Satoshi Kuwabara
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease that favors the cerebrum and typically occurs in immunosuppressed patients. We herein report the case of a 66-year-old man with PML, idiopathic CD4(+) T lymphocytopenia (ICL), and chronic renal failure. Cranial magnetic resonance imaging (MRI) showed a crescent-shaped lesion in the left cerebellum, brainstem, and middle cerebellar peduncle. Although the patient did not present with HIV infection, collagen diseases, or tumors, JC virus DNA was detected in the cerebrospinal fluid. Clinicians should consider PML and ICL in the differential diagnosis if the patient develops progressive ataxia and a crescent-shaped cerebellar lesion on MRI.

1 January 2020 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
SFShogo Furukawa
Shogo Furukawa
SHShigeki Hirano
Shigeki Hirano
TYTatsuya Yamamoto
Tatsuya Yamamoto
MAMasato Asahina
Masato Asahina
TUTomoyuki Uchiyama
Tomoyuki Uchiyama
SKSatoshi Kuwabara
Satoshi Kuwabara

1 May 2023 in Stroke
Verified
Journal Article
Closed access
AHAkiyuki Hiraga
Akiyuki Hiraga
KKKentaro Kurumada
Kentaro Kurumada
KKKazuho Kojima
Kazuho Kojima
SKSatoshi Kuwabara
Satoshi Kuwabara